
Dr. Mark Storey MD - Radiation Oncologist. @OKProtonCenter. Background: #MDAnderson @VanderbiltU @BMESociety #RadOnc My blog: https://nitter.cf/t.co/4S0MeQiWEI
Oklahoma City, OK
Joined June 2019
- Tweets4.5K
- Following442
- Followers1.7K
- Likes8.8K
Pinned Tweet
If radiation were a drug....
Full editorial on my blog. #radonc
This is literally one of the few standing - treat beyond the tumor instances. As I've argued, it too shall eventually fall into the singularity.
pubmed.ncbi.nlm.nih.gov/4302…
脊椎SBRTはやっぱりコンツーリングと最適化作業が何となくストレスなのでsegmentのコンツーリングでなくGTVにmarginが基本で楽にコンツーリング出来るなら楽だし骨折も減るだろうし恐らく症例増えれば神経障害も減りそうだしそれでlocal control不良じゃないなら助かる…
Mark Storey retweeted
pubmed.ncbi.nlm.nih.gov/4302…
脊椎SBRTはやっぱりコンツーリングと最適化作業が何となくストレスなのでsegmentのコンツーリングでなくGTVにmarginが基本で楽にコンツーリング出来るなら楽だし骨折も減るだろうし恐らく症例増えれば神経障害も減りそうだしそれでlocal control不良じゃないなら助かる…
The march towards more (relative) dose in what in see and less dose elsewhere continues. All sites - everywhere - our Singularity. When HN and breast collapse, many more will fully appreciate the path.
Now in @JAMAOnc:
We report 5y outcomes post 30 Gy elective RT (total 70 Gy CCRT) for 276 pts w/ HPV-related OPC #hncsm at @MSKCancerCenter #radonc
LRC 97.0%
OS 90.8%
PFS 85.9%
DMFS 91.2%
@imrtlee @xrtGenomics @seanmmcbride @CJTsaiMDPhD @EChrisDee
👉 shorturl.at/liqpP
For those following along - progressed to a one shot prompt is now where we are - we'll see how this holds up DASL-HiCaP prediction for ESMO.
See feed or highlights etc for more info on the framework.
249
If I were still practicing, I'd have a single Grok bot assigned per patient - tracking every new input - monitoring everything added to the chart. Daily report - obviously checked and verified by a review bot.
IT would be getting a daily visit until this was approved.
Regardless of thoughts on when / if protons have value - 30% site of service proposal is still crazy.
Thought we had momentum towards removing this type of discrepancy.
If you can't look ahead and see the Singularity as I've discussed, don't know what to say... First add, then substract. Now 6 months ago...
LUNAR Trial:
pubmed.ncbi.nlm.nih.gov/4286…
4
3
1,292
Next goal is integration with a couple of Grok bots who are watching X - creating lists to add. Ranking the list of candidates which I then feed into the CLI because I still think the harness there is stronger for the work. Goal is a relatively low work loop. Crazy world.
14 of 18 truly prospective calls correct. Importantly the pre-set discrimination line (pretty visible where it would be from image below) held. Every call above it remained accurate (7 for 7). All four misses below (7 for 11).
Basic trends continued further - upper right best. Lower left worst at meeting endpoints. Quadrants drawn previously continue to hold along with the discrimination line.
Simple concept - use this structured analysis to review your trial design and look for ways to simply ask the same question better. More to follow on the Substack as I put together a complete document of the 18 calls - what went right and why CNS and our historical slant (probably too much in favor of too much treatment in the brain) appears responsible for all 4 of the misses.
A week later and more digging through the data, and I'm more certain - it is the end of the era in CNS to treat beyond what you see.
2
307
14 of 18 truly prospective calls correct. Importantly the pre-set discrimination line (pretty visible where it would be from image below) held. Every call above it remained accurate (7 for 7). All four misses below (7 for 11).
Basic trends continued further - upper right best. Lower left worst at meeting endpoints. Quadrants drawn previously continue to hold along with the discrimination line.
Simple concept - use this structured analysis to review your trial design and look for ways to simply ask the same question better. More to follow on the Substack as I put together a complete document of the 18 calls - what went right and why CNS and our historical slant (probably too much in favor of too much treatment in the brain) appears responsible for all 4 of the misses.
A week later and more digging through the data, and I'm more certain - it is the end of the era in CNS to treat beyond what you see.
FYI - here were the final results with 36 votes. 2/3rds moving aggressively towards multiple fractions - the question appears to be in small lesions.
Post A071801 - post op brain cavity single fx vs. 3 fraction. Will you treat single fraction?
0%Yes
67%No
33%If small, <2cm
0%cost, efficiency reasons
36 votes • Final results 2
539
Digging through data and slides from a busy ASTRO - I think this slide over-states the data and math. The 5 yr data does not support NI for EPIC urinary outcomes.
Bullet point 1. The two year primary endpoint DID exclude non-inferiority - barely. Mean difference of -0.9 and a CI (-4.63 to 2.83) that excluded their own 5 point EPIC NI metric.
So in the 5 year data - a few things progressed - the physician data showed worse outcomes. AND the patient mean drifted more inferior as well. To -2.3 from -0.9. People dropped out and so the confidence interval widened - now -7.7 which now covers a 5 point relative drop. Can't use the slide SD - have to convert to a 95% CI - that is the metric a NI uses.
P value alone here is not sufficient to state "remains non-inferior". I believe this is classic absence of evidence being worded on a cooperative group slide as evidence of absence.
I'm not talking about the higher dose etc - just literal read of the conclusions vs. the data.
I know most will think this is just in the weeds stuff, but precision is important. Maybe they had a broader 5 year definition of NI but I couldn't find it.
Anyone agree or did I miss something?
Thank you - write ups are relatively easy - the clinical trial work is what takes years of commitment. Keep it up. Great month in CNS.
Replying to @ProtonStorey
Great job on your WBRT SRS post btw. For both studied we collected blood but did not collect CBC information
2
417
cc-009 and MAVERICK - do we have good CBC data weekly or biweekly through the treatment period and say 2 week beyond EOT? My modeling says lymphopenia might be a driving force for the OS.
@PDBrownOnc
Post A071801 - post op brain cavity single fx vs. 3 fraction. Will you treat single fraction?
0%Yes
67%No
33%If small, <2cm
0%cost, efficiency reasons
36 votes • Final resultsSunday - MAVERICK, CC009, FIRE-SCLC and the non-small cell study for completeness.
A story about where we were 30 years ago and the data driven progress since.
5
471
these are AI derived curves - don't use them. for example - the presented OS curve . 10 bookmarks - just sayin....
NRG CC009 Trial
First randomized phase III comparison of SRS vs hippocampal-avoidant WBRT + memantine specifically in SCLC brain metastases
Trial with Double surprise
Primary end point = Fails
Secondary end point = Astonishes
3
9
3,470
Amazing device. Needs a code to differentiate. 1 and 10 aren't the same complexity or value.
Replying to @DrewMoghanaki
Finally, we learned this device can treat 10 targets at once, in 97 seconds!
Mark Storey retweeted
A Nova Scotia woman had precancerous cells on her cervix.
That was two years ago.
Pap smear. Abnormal cells. Referral to a gynecologist so they could find out if it was cancer. The referral sat for nine months.
She finally gets an appointment. She shows up on time — 10 a.m., in her calendar. The office says it was at 9. Won’t see her. Won’t reschedule. Start over. New referral.
She leaves crying. Seven more months go by. They call about an appointment she was never told about. She can’t take it.
She’s on a TV contract. Miss it and they can sue her.
Next opening: next year.
They don’t even call her back. She has to chase them.
She said the quiet part out loud: imagine dying of cervical cancer while you wait just to see a gyno.
That is Canada’s “universal healthcare.”
Not free care. A government monopoly that loses your referral, punishes you for their scheduling error, and hands a possible cancer case a calendar date in another year.
Coverage on paper. Care on a waitlist. You pay the taxes either way. The state decides when you’re allowed to find out if you have cancer.
This is the model they want to import as Medicare for All.
Don’t.



















